Regeneron Pharmaceuticals Said Single Administration Of CIDEB(siRNA) Led To Reductions In Liver Fat Up To 80% That Were Sustained Through 36 Weeks
Nov 8 (Reuters) - Regeneron Pharmaceuticals, Inc. REGN.O:
REGENERON PHARMACEUTICALS, INC.: SINGLE ADMINISTRATION OF CIDEB(SIRNA) LED TO REDUCTIONS IN LIVER FAT UP TO 80% THAT WERE SUSTAINED THROUGH 36 WEEKS
Further company coverage: REGN.O